Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer. (Q33186647)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer. |
scientific article |
Statements
Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer (English)
Els M J J Berns
Jan G M Klijn
Maxime P Look
Nicolai Grebenchtchikov
Rolf Vossen
Harry Peters
Anneke Geurts-Moespot
Henk Portengen
Iris L van Staveren
Marion E Meijer-van Gelder
Bert Bakker
Fred C G J Sweep
John A Foekens